Vitamins unit proves costly for Roche 2002
Reporting its results for 2002, Swiss pharmaceuticals group Roche said the sale of its vitamins division and legal settlements with US customers in the vitamin case will result in significant one-time charges and a net loss of SF4 billion (€2.7bn).